Loading clinical trials...

Ultrasound Evaluations of Diaphragm and Intercostal Muscle to Predict the Failure of High-Flow Nasal Cannula Therapy | Clinical Trials | Clareo Health

RECRUITING

Ultrasound Evaluations of Diaphragm and Intercostal Muscle to Predict the Failure of High-Flow Nasal Cannula Therapy

NCT06375538•Shanghai Zhongshan Hospital

View on ClinicalTrials.gov

Summary

The study aims to predict the failure of High-flow Nasal Cannula oxygenation therapy by ultrasound evaluation of diaphragm and intercostal muscle contraction during the first 24 hours.

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•more than 18 years old
•needing High-flow Nasal Cannula oxygenation therapy

Exclusion Criteria

•received mechanical ventilation, including invasive or noninvasive ventilation within one month prior to enrollment
•history of neuromuscular disorders (e.g., myasthenia gravis, Guillain-Barre syndrome);
•immediate endotracheal intubation is required (life-threatening hypoxemia)
•extensive damage to the thoracic skin (e.g., burns) unable to undergo ultrasonography
•pregnancy
•attending physician deemed it inappropriate to participate in the trial.

Locations (1)

Shanghai Zhongshan Hospital

Shanghai, Shanghai Municipality, China

Key Dates

Start Date

October 21, 2022

Primary Completion Date

August 31, 2025

Completion Date

December 31, 2025

Last Updated

April 19, 2024

Enrollment

200

ESTIMATED participants

Conditions

High-flow Nasal CannulaUltrasound EvaluationDiaphragm and Intercostal Muscle

Contacts

Wei Wu

CONTACT

13817976707 wu.wei1@zs-hospital.sh.cn

Validating the Speckle Tracking Methods on Soft Tissue Strain, Displacement, and Roles in Physical Therapy

NCT07485530

Ulnar Collateral Ligament SprainTibialis Posterior Dysfunction+2 more

View study

RECRUITINGNA

A RCT on the Preventive Effect of HFNC on Postoperative Pulmonary Complications in Patients With Gynecologic Neoplasms

NCT05526534

Gynecologic SurgeryHigh-flow Nasal Cannula+1 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 19, 2024Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Ultrasound Evaluations of Diaphragm and Intercostal Muscle to Predict the Failure of High-Flow Nasal Cannula Therapy

Inclusion Criteria

Exclusion Criteria

Validating the Speckle Tracking Methods on Soft Tissue Strain, Displacement, and Roles in Physical Therapy

A RCT on the Preventive Effect of HFNC on Postoperative Pulmonary Complications in Patients With Gynecologic Neoplasms

Assessing the Relationship Between Frailty and Skeletal Muscle Thickness in Critically Ill Patients

Prevalence of Sarcopenia in Patients Admitted to ICU and Its Progression During Hospitalization.

Protocolized Weaning of High-Flow Nasal Cannula in Adult Patients

High Flow Nasal Cannula in Patients Undergoing ERCP Retrograde Cholangiopancreatography With Intravenous Sedation.